nodes	percent_of_prediction	percent_of_DWPC	metapath
Linezolid—MAOB—Alpha-synuclein signaling—UCHL1—lung cancer	0.00893	0.0539	CbGpPWpGaD
Linezolid—MAOB—Dopamine metabolism—NQO1—lung cancer	0.00812	0.049	CbGpPWpGaD
Linezolid—MAOB—Tryptophan metabolism—HSD17B10—lung cancer	0.00766	0.0462	CbGpPWpGaD
Linezolid—Rivaroxaban—ABCB1—lung cancer	0.00691	1	CrCbGaD
Linezolid—MAOB—Alpha-synuclein signaling—FGR—lung cancer	0.00603	0.0364	CbGpPWpGaD
Linezolid—MAOA—Dopamine metabolism—NQO1—lung cancer	0.0051	0.0308	CbGpPWpGaD
Linezolid—MAOB—Phase 1 - Functionalization of compounds—CYP2A7—lung cancer	0.00397	0.0239	CbGpPWpGaD
Linezolid—MAOA—Oxidative Stress—NFE2L2—lung cancer	0.00361	0.0218	CbGpPWpGaD
Linezolid—MAOA—Oxidative Stress—GCLC—lung cancer	0.0031	0.0187	CbGpPWpGaD
Linezolid—MAOB—Tryptophan metabolism—CYP2E1—lung cancer	0.00299	0.018	CbGpPWpGaD
Linezolid—MAOA—Oxidative Stress—NQO1—lung cancer	0.00261	0.0158	CbGpPWpGaD
Linezolid—MAOA—Oxidative Stress—JUNB—lung cancer	0.00259	0.0156	CbGpPWpGaD
Linezolid—MAOA—Phase 1 - Functionalization of compounds—CYP2A7—lung cancer	0.00249	0.015	CbGpPWpGaD
Linezolid—MAOB—Tryptophan metabolism—CAT—lung cancer	0.0024	0.0145	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—GSTM2—lung cancer	0.00233	0.0141	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—CNDP2—lung cancer	0.00233	0.0141	CbGpPWpGaD
Linezolid—MAOB—Phase 1 - Functionalization of compounds—CYP2A6—lung cancer	0.0023	0.0139	CbGpPWpGaD
Linezolid—MAOB—Tryptophan metabolism—CYP1A1—lung cancer	0.00215	0.013	CbGpPWpGaD
Linezolid—MAOA—Oxidative Stress—CAT—lung cancer	0.00212	0.0128	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—CYP2A7—lung cancer	0.00211	0.0127	CbGpPWpGaD
Linezolid—MAOA—Oxidative Stress—SOD2—lung cancer	0.00201	0.0121	CbGpPWpGaD
Linezolid—MAOB—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	0.00196	0.0118	CbGpPWpGaD
Linezolid—MAOA—Melatonin metabolism and effects—CYP1A1—lung cancer	0.00195	0.0118	CbGpPWpGaD
Linezolid—MAOA—Oxidative Stress—CYP1A1—lung cancer	0.0019	0.0114	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—GSTA3—lung cancer	0.00188	0.0113	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—GSTA4—lung cancer	0.00172	0.0104	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—GSTA2—lung cancer	0.00167	0.0101	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—GSTA1—lung cancer	0.00161	0.00975	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—UGT1A1—lung cancer	0.0015	0.00906	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—CNDP2—lung cancer	0.00146	0.00882	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—GSTM2—lung cancer	0.00146	0.00882	CbGpPWpGaD
Linezolid—MAOA—Phase 1 - Functionalization of compounds—CYP2A6—lung cancer	0.00145	0.00873	CbGpPWpGaD
Linezolid—MAOB—Alpha-synuclein signaling—SRC—lung cancer	0.00142	0.00855	CbGpPWpGaD
Linezolid—MAOB—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	0.00141	0.00849	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—GRIK3—lung cancer	0.00138	0.00832	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—CHRNB4—lung cancer	0.00137	0.00827	CbGpPWpGaD
Linezolid—MAOB—Tryptophan metabolism—MDM2—lung cancer	0.00132	0.008	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—CYP2A7—lung cancer	0.00132	0.00798	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—HPGDS—lung cancer	0.00128	0.0077	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—GSTT1—lung cancer	0.00124	0.00747	CbGpPWpGaD
Linezolid—MAOA—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	0.00123	0.00742	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—GCLC—lung cancer	0.00122	0.00739	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—CYP2A6—lung cancer	0.00122	0.00739	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—GSTA3—lung cancer	0.00118	0.00711	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—CHRNB4—lung cancer	0.00112	0.00678	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—GSTA4—lung cancer	0.00108	0.0065	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—GRIK3—lung cancer	0.00106	0.00637	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—GSTA2—lung cancer	0.00105	0.00634	CbGpPWpGaD
Linezolid—MAOB—Phase 1 - Functionalization of compounds—POMC—lung cancer	0.00105	0.00633	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—CHRNA5—lung cancer	0.00104	0.0063	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—CYP2E1—lung cancer	0.00104	0.00628	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—FOXM1—lung cancer	0.00104	0.00627	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—GSTA1—lung cancer	0.00101	0.00612	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—SOX2—lung cancer	0.000966	0.00583	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—UGT1A1—lung cancer	0.000942	0.00569	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—ALDOA—lung cancer	0.000935	0.00564	CbGpPWpGaD
Linezolid—MAOA—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	0.000883	0.00533	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—CHRNB4—lung cancer	0.000861	0.0052	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—GSTP1—lung cancer	0.000858	0.00518	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—CHRNA3—lung cancer	0.000851	0.00514	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—TF—lung cancer	0.000821	0.00496	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—GNG11—lung cancer	0.000805	0.00486	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—HPGDS—lung cancer	0.000801	0.00483	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—CHRNA5—lung cancer	0.0008	0.00483	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—GSTM1—lung cancer	0.000789	0.00476	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—GSTT1—lung cancer	0.000777	0.00469	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—CYP2A6—lung cancer	0.000768	0.00464	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—GCLC—lung cancer	0.000768	0.00464	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—CYP1A1—lung cancer	0.000748	0.00451	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—ADCY1—lung cancer	0.000724	0.00437	CbGpPWpGaD
Linezolid—MAOA—Phase 1 - Functionalization of compounds—POMC—lung cancer	0.000658	0.00397	CbGpPWpGaD
Linezolid—MAOB—Metabolism—COL4A3BP—lung cancer	0.000658	0.00397	CbGpPWpGaD
Linezolid—MAOB—Metabolism—AZIN2—lung cancer	0.000658	0.00397	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—CYP2E1—lung cancer	0.000653	0.00394	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—CHRNA3—lung cancer	0.000652	0.00394	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—GNG11—lung cancer	0.000617	0.00372	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—AVP—lung cancer	0.000569	0.00343	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ATP5H—lung cancer	0.000559	0.00337	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—POMC—lung cancer	0.000557	0.00336	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—ADCY1—lung cancer	0.000555	0.00335	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—GSTP1—lung cancer	0.000538	0.00325	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—HES1—lung cancer	0.000538	0.00325	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—IL10—lung cancer	0.000535	0.00323	CbGpPWpGaD
Linezolid—Pruritus—Vinorelbine—lung cancer	0.000527	0.000637	CcSEcCtD
Linezolid—Pain—Irinotecan—lung cancer	0.000525	0.000635	CcSEcCtD
Linezolid—Constipation—Irinotecan—lung cancer	0.000525	0.000635	CcSEcCtD
Linezolid—Erythema—Docetaxel—lung cancer	0.00052	0.000629	CcSEcCtD
Linezolid—Decreased appetite—Gemcitabine—lung cancer	0.00052	0.000629	CcSEcCtD
Linezolid—Nausea—Topotecan—lung cancer	0.000517	0.000625	CcSEcCtD
Linezolid—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000517	0.000624	CcSEcCtD
Linezolid—Fatigue—Gemcitabine—lung cancer	0.000516	0.000624	CcSEcCtD
Linezolid—Pain—Gemcitabine—lung cancer	0.000512	0.000619	CcSEcCtD
Linezolid—Constipation—Gemcitabine—lung cancer	0.000512	0.000619	CcSEcCtD
Linezolid—Nausea—Erlotinib—lung cancer	0.000512	0.000619	CcSEcCtD
Linezolid—Pancytopenia—Methotrexate—lung cancer	0.000511	0.000618	CcSEcCtD
Linezolid—Dry mouth—Paclitaxel—lung cancer	0.000511	0.000618	CcSEcCtD
Linezolid—Anaphylactic shock—Etoposide—lung cancer	0.000511	0.000618	CcSEcCtD
Linezolid—Diarrhoea—Vinorelbine—lung cancer	0.00051	0.000616	CcSEcCtD
Linezolid—Dysgeusia—Docetaxel—lung cancer	0.00051	0.000616	CcSEcCtD
Linezolid—Neutropenia—Methotrexate—lung cancer	0.000503	0.000608	CcSEcCtD
Linezolid—Gastrointestinal pain—Irinotecan—lung cancer	0.000502	0.000607	CcSEcCtD
Linezolid—Anaphylactic shock—Paclitaxel—lung cancer	0.000501	0.000606	CcSEcCtD
Linezolid—Paraesthesia—Cisplatin—lung cancer	0.000501	0.000605	CcSEcCtD
Linezolid—Thrombocytopenia—Etoposide—lung cancer	0.0005	0.000605	CcSEcCtD
Linezolid—Muscle spasms—Docetaxel—lung cancer	0.0005	0.000605	CcSEcCtD
Linezolid—Upper respiratory tract infection—Methotrexate—lung cancer	0.0005	0.000605	CcSEcCtD
Linezolid—MAOB—Metabolism—PLBD1—lung cancer	0.000498	0.00301	CbGpPWpGaD
Linezolid—Liver function test abnormal—Doxorubicin—lung cancer	0.000498	0.000602	CcSEcCtD
Linezolid—Dyspnoea—Cisplatin—lung cancer	0.000497	0.000601	CcSEcCtD
Linezolid—Skin disorder—Etoposide—lung cancer	0.000496	0.0006	CcSEcCtD
Linezolid—MAOA—Biological oxidations—GSTM1—lung cancer	0.000495	0.00299	CbGpPWpGaD
Linezolid—Hyperhidrosis—Etoposide—lung cancer	0.000494	0.000597	CcSEcCtD
Linezolid—Dizziness—Vinorelbine—lung cancer	0.000493	0.000595	CcSEcCtD
Linezolid—Hypokalaemia—Doxorubicin—lung cancer	0.000491	0.000593	CcSEcCtD
Linezolid—Thrombocytopenia—Paclitaxel—lung cancer	0.000491	0.000593	CcSEcCtD
Linezolid—Anorexia—Etoposide—lung cancer	0.000487	0.000589	CcSEcCtD
Linezolid—Skin disorder—Paclitaxel—lung cancer	0.000487	0.000588	CcSEcCtD
Linezolid—Body temperature increased—Irinotecan—lung cancer	0.000486	0.000587	CcSEcCtD
Linezolid—Abdominal pain—Irinotecan—lung cancer	0.000486	0.000587	CcSEcCtD
Linezolid—Aspartate aminotransferase increased—Doxorubicin—lung cancer	0.000486	0.000587	CcSEcCtD
Linezolid—Decreased appetite—Cisplatin—lung cancer	0.000485	0.000586	CcSEcCtD
Linezolid—Hyperhidrosis—Paclitaxel—lung cancer	0.000484	0.000585	CcSEcCtD
Linezolid—Pneumonia—Methotrexate—lung cancer	0.000483	0.000583	CcSEcCtD
Linezolid—Gastrointestinal disorder—Cisplatin—lung cancer	0.000482	0.000582	CcSEcCtD
Linezolid—Anaemia—Docetaxel—lung cancer	0.000481	0.000581	CcSEcCtD
Linezolid—Anorexia—Paclitaxel—lung cancer	0.000478	0.000577	CcSEcCtD
Linezolid—Gastritis—Doxorubicin—lung cancer	0.000477	0.000577	CcSEcCtD
Linezolid—Pain—Cisplatin—lung cancer	0.000477	0.000577	CcSEcCtD
Linezolid—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.000476	0.000575	CcSEcCtD
Linezolid—Alanine aminotransferase increased—Doxorubicin—lung cancer	0.000476	0.000575	CcSEcCtD
Linezolid—Vomiting—Vinorelbine—lung cancer	0.000474	0.000572	CcSEcCtD
Linezolid—Body temperature increased—Gemcitabine—lung cancer	0.000473	0.000572	CcSEcCtD
Linezolid—Renal failure—Methotrexate—lung cancer	0.000472	0.00057	CcSEcCtD
Linezolid—Rash—Vinorelbine—lung cancer	0.00047	0.000568	CcSEcCtD
Linezolid—Dermatitis—Vinorelbine—lung cancer	0.000469	0.000567	CcSEcCtD
Linezolid—MAOA—Biological oxidations—CYP1A1—lung cancer	0.000469	0.00283	CbGpPWpGaD
Linezolid—Stomatitis—Methotrexate—lung cancer	0.000468	0.000565	CcSEcCtD
Linezolid—Headache—Vinorelbine—lung cancer	0.000467	0.000564	CcSEcCtD
Linezolid—Leukopenia—Docetaxel—lung cancer	0.000466	0.000563	CcSEcCtD
Linezolid—Eosinophilia—Doxorubicin—lung cancer	0.000461	0.000558	CcSEcCtD
Linezolid—Paraesthesia—Etoposide—lung cancer	0.000459	0.000555	CcSEcCtD
Linezolid—Pancreatitis—Doxorubicin—lung cancer	0.000457	0.000552	CcSEcCtD
Linezolid—MAOB—Metabolism—HSD17B10—lung cancer	0.000456	0.00275	CbGpPWpGaD
Linezolid—Dyspnoea—Etoposide—lung cancer	0.000456	0.000551	CcSEcCtD
Linezolid—Somnolence—Etoposide—lung cancer	0.000454	0.000549	CcSEcCtD
Linezolid—Cough—Docetaxel—lung cancer	0.000454	0.000549	CcSEcCtD
Linezolid—Insomnia—Paclitaxel—lung cancer	0.000453	0.000548	CcSEcCtD
Linezolid—MAOA—SIDS Susceptibility Pathways—HIF1A—lung cancer	0.000451	0.00272	CbGpPWpGaD
Linezolid—Convulsion—Docetaxel—lung cancer	0.000451	0.000545	CcSEcCtD
Linezolid—Paraesthesia—Paclitaxel—lung cancer	0.00045	0.000544	CcSEcCtD
Linezolid—Hypertension—Docetaxel—lung cancer	0.000449	0.000543	CcSEcCtD
Linezolid—Dyspnoea—Paclitaxel—lung cancer	0.000447	0.00054	CcSEcCtD
Linezolid—Somnolence—Paclitaxel—lung cancer	0.000445	0.000538	CcSEcCtD
Linezolid—Decreased appetite—Etoposide—lung cancer	0.000444	0.000537	CcSEcCtD
Linezolid—Pancytopenia—Doxorubicin—lung cancer	0.000443	0.000535	CcSEcCtD
Linezolid—Nausea—Vinorelbine—lung cancer	0.000442	0.000535	CcSEcCtD
Linezolid—Gastrointestinal disorder—Etoposide—lung cancer	0.000441	0.000533	CcSEcCtD
Linezolid—Dyspepsia—Paclitaxel—lung cancer	0.000441	0.000533	CcSEcCtD
Linezolid—Body temperature increased—Cisplatin—lung cancer	0.000441	0.000533	CcSEcCtD
Linezolid—Asthenia—Irinotecan—lung cancer	0.000441	0.000533	CcSEcCtD
Linezolid—Fatigue—Etoposide—lung cancer	0.000441	0.000532	CcSEcCtD
Linezolid—Pain—Etoposide—lung cancer	0.000437	0.000528	CcSEcCtD
Linezolid—Constipation—Etoposide—lung cancer	0.000437	0.000528	CcSEcCtD
Linezolid—Neutropenia—Doxorubicin—lung cancer	0.000436	0.000527	CcSEcCtD
Linezolid—Decreased appetite—Paclitaxel—lung cancer	0.000436	0.000526	CcSEcCtD
Linezolid—Dry mouth—Docetaxel—lung cancer	0.000433	0.000524	CcSEcCtD
Linezolid—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000433	0.000524	CcSEcCtD
Linezolid—Haemoglobin—Methotrexate—lung cancer	0.000433	0.000523	CcSEcCtD
Linezolid—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000433	0.000523	CcSEcCtD
Linezolid—Fatigue—Paclitaxel—lung cancer	0.000432	0.000522	CcSEcCtD
Linezolid—Haemorrhage—Methotrexate—lung cancer	0.000431	0.000521	CcSEcCtD
Linezolid—Asthenia—Gemcitabine—lung cancer	0.000429	0.000519	CcSEcCtD
Linezolid—Pain—Paclitaxel—lung cancer	0.000428	0.000518	CcSEcCtD
Linezolid—Constipation—Paclitaxel—lung cancer	0.000428	0.000518	CcSEcCtD
Linezolid—Pharyngitis—Methotrexate—lung cancer	0.000428	0.000517	CcSEcCtD
Linezolid—Anaphylactic shock—Docetaxel—lung cancer	0.000425	0.000513	CcSEcCtD
Linezolid—MAOB—Metabolism—CKB—lung cancer	0.000424	0.00256	CbGpPWpGaD
Linezolid—Pruritus—Gemcitabine—lung cancer	0.000423	0.000512	CcSEcCtD
Linezolid—Hyperglycaemia—Doxorubicin—lung cancer	0.00042	0.000508	CcSEcCtD
Linezolid—Diarrhoea—Irinotecan—lung cancer	0.00042	0.000508	CcSEcCtD
Linezolid—Pneumonia—Doxorubicin—lung cancer	0.000418	0.000505	CcSEcCtD
Linezolid—Gastrointestinal pain—Etoposide—lung cancer	0.000418	0.000505	CcSEcCtD
Linezolid—Thrombocytopenia—Docetaxel—lung cancer	0.000416	0.000503	CcSEcCtD
Linezolid—MAOA—Metabolism—COL4A3BP—lung cancer	0.000413	0.00249	CbGpPWpGaD
Linezolid—MAOA—Metabolism—AZIN2—lung cancer	0.000413	0.00249	CbGpPWpGaD
Linezolid—Skin disorder—Docetaxel—lung cancer	0.000413	0.000499	CcSEcCtD
Linezolid—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000412	0.000498	CcSEcCtD
Linezolid—Gastrointestinal pain—Paclitaxel—lung cancer	0.00041	0.000495	CcSEcCtD
Linezolid—Diarrhoea—Gemcitabine—lung cancer	0.000409	0.000495	CcSEcCtD
Linezolid—Renal failure—Doxorubicin—lung cancer	0.000409	0.000494	CcSEcCtD
Linezolid—Erythema multiforme—Methotrexate—lung cancer	0.000407	0.000492	CcSEcCtD
Linezolid—Neuropathy peripheral—Doxorubicin—lung cancer	0.000407	0.000492	CcSEcCtD
Linezolid—Dizziness—Irinotecan—lung cancer	0.000406	0.000491	CcSEcCtD
Linezolid—Urticaria—Etoposide—lung cancer	0.000406	0.000491	CcSEcCtD
Linezolid—Stomatitis—Doxorubicin—lung cancer	0.000405	0.00049	CcSEcCtD
Linezolid—Anorexia—Docetaxel—lung cancer	0.000405	0.000489	CcSEcCtD
Linezolid—Abdominal pain—Etoposide—lung cancer	0.000404	0.000488	CcSEcCtD
Linezolid—Body temperature increased—Etoposide—lung cancer	0.000404	0.000488	CcSEcCtD
Linezolid—Tinnitus—Methotrexate—lung cancer	0.000402	0.000486	CcSEcCtD
Linezolid—Asthenia—Cisplatin—lung cancer	0.0004	0.000484	CcSEcCtD
Linezolid—MAOB—Metabolism—GSTM2—lung cancer	0.000398	0.0024	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CNDP2—lung cancer	0.000398	0.0024	CbGpPWpGaD
Linezolid—Urticaria—Paclitaxel—lung cancer	0.000398	0.000481	CcSEcCtD
Linezolid—Body temperature increased—Paclitaxel—lung cancer	0.000396	0.000479	CcSEcCtD
Linezolid—Abdominal pain—Paclitaxel—lung cancer	0.000396	0.000479	CcSEcCtD
Linezolid—Vomiting—Irinotecan—lung cancer	0.000391	0.000472	CcSEcCtD
Linezolid—MAOB—Metabolism—MTMR3—lung cancer	0.000388	0.00234	CbGpPWpGaD
Linezolid—Rash—Irinotecan—lung cancer	0.000387	0.000468	CcSEcCtD
Linezolid—Dermatitis—Irinotecan—lung cancer	0.000387	0.000468	CcSEcCtD
Linezolid—Chills—Methotrexate—lung cancer	0.000387	0.000467	CcSEcCtD
Linezolid—Headache—Irinotecan—lung cancer	0.000385	0.000465	CcSEcCtD
Linezolid—Insomnia—Docetaxel—lung cancer	0.000384	0.000464	CcSEcCtD
Linezolid—Diarrhoea—Cisplatin—lung cancer	0.000382	0.000461	CcSEcCtD
Linezolid—Paraesthesia—Docetaxel—lung cancer	0.000381	0.000461	CcSEcCtD
Linezolid—Vomiting—Gemcitabine—lung cancer	0.000381	0.00046	CcSEcCtD
Linezolid—Dyspnoea—Docetaxel—lung cancer	0.000379	0.000458	CcSEcCtD
Linezolid—MAOB—Metabolism—PGAM1—lung cancer	0.000378	0.00228	CbGpPWpGaD
Linezolid—Somnolence—Docetaxel—lung cancer	0.000378	0.000456	CcSEcCtD
Linezolid—Rash—Gemcitabine—lung cancer	0.000377	0.000456	CcSEcCtD
Linezolid—Dermatitis—Gemcitabine—lung cancer	0.000377	0.000456	CcSEcCtD
Linezolid—Erythema—Methotrexate—lung cancer	0.000375	0.000453	CcSEcCtD
Linezolid—Haemoglobin—Doxorubicin—lung cancer	0.000375	0.000453	CcSEcCtD
Linezolid—Headache—Gemcitabine—lung cancer	0.000375	0.000453	CcSEcCtD
Linezolid—Dyspepsia—Docetaxel—lung cancer	0.000374	0.000452	CcSEcCtD
Linezolid—Haemorrhage—Doxorubicin—lung cancer	0.000373	0.000451	CcSEcCtD
Linezolid—Hypoaesthesia—Doxorubicin—lung cancer	0.000371	0.000449	CcSEcCtD
Linezolid—Pharyngitis—Doxorubicin—lung cancer	0.00037	0.000448	CcSEcCtD
Linezolid—Decreased appetite—Docetaxel—lung cancer	0.000369	0.000446	CcSEcCtD
Linezolid—MAOA—SIDS Susceptibility Pathways—IL6R—lung cancer	0.000369	0.00223	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—CREBBP—lung cancer	0.000368	0.00222	CbGpPWpGaD
Linezolid—Dysgeusia—Methotrexate—lung cancer	0.000367	0.000444	CcSEcCtD
Linezolid—Gastrointestinal disorder—Docetaxel—lung cancer	0.000367	0.000443	CcSEcCtD
Linezolid—Asthenia—Etoposide—lung cancer	0.000367	0.000443	CcSEcCtD
Linezolid—Fatigue—Docetaxel—lung cancer	0.000366	0.000443	CcSEcCtD
Linezolid—Nausea—Irinotecan—lung cancer	0.000365	0.000441	CcSEcCtD
Linezolid—Pain—Docetaxel—lung cancer	0.000363	0.000439	CcSEcCtD
Linezolid—Constipation—Docetaxel—lung cancer	0.000363	0.000439	CcSEcCtD
Linezolid—Pruritus—Etoposide—lung cancer	0.000362	0.000437	CcSEcCtD
Linezolid—MAOB—Metabolism—CYP2A7—lung cancer	0.00036	0.00217	CbGpPWpGaD
Linezolid—Asthenia—Paclitaxel—lung cancer	0.00036	0.000434	CcSEcCtD
Linezolid—Nausea—Gemcitabine—lung cancer	0.000355	0.00043	CcSEcCtD
Linezolid—Vomiting—Cisplatin—lung cancer	0.000355	0.000429	CcSEcCtD
Linezolid—Pruritus—Paclitaxel—lung cancer	0.000355	0.000428	CcSEcCtD
Linezolid—Vision blurred—Methotrexate—lung cancer	0.000353	0.000427	CcSEcCtD
Linezolid—Erythema multiforme—Doxorubicin—lung cancer	0.000353	0.000426	CcSEcCtD
Linezolid—MAOB—Metabolism—SDC4—lung cancer	0.000353	0.00213	CbGpPWpGaD
Linezolid—Rash—Cisplatin—lung cancer	0.000352	0.000425	CcSEcCtD
Linezolid—Dermatitis—Cisplatin—lung cancer	0.000351	0.000425	CcSEcCtD
Linezolid—MAOA—Metabolism—ATP5H—lung cancer	0.000351	0.00212	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—POMC—lung cancer	0.00035	0.00211	CbGpPWpGaD
Linezolid—Diarrhoea—Etoposide—lung cancer	0.00035	0.000423	CcSEcCtD
Linezolid—Tinnitus—Doxorubicin—lung cancer	0.000348	0.00042	CcSEcCtD
Linezolid—Gastrointestinal pain—Docetaxel—lung cancer	0.000347	0.00042	CcSEcCtD
Linezolid—Anaemia—Methotrexate—lung cancer	0.000347	0.000419	CcSEcCtD
Linezolid—Diarrhoea—Paclitaxel—lung cancer	0.000343	0.000414	CcSEcCtD
Linezolid—Dizziness—Etoposide—lung cancer	0.000338	0.000408	CcSEcCtD
Linezolid—Vertigo—Methotrexate—lung cancer	0.000337	0.000407	CcSEcCtD
Linezolid—Abdominal pain—Docetaxel—lung cancer	0.000336	0.000406	CcSEcCtD
Linezolid—Body temperature increased—Docetaxel—lung cancer	0.000336	0.000406	CcSEcCtD
Linezolid—Leukopenia—Methotrexate—lung cancer	0.000336	0.000406	CcSEcCtD
Linezolid—Chills—Doxorubicin—lung cancer	0.000335	0.000405	CcSEcCtD
Linezolid—Dizziness—Paclitaxel—lung cancer	0.000331	0.0004	CcSEcCtD
Linezolid—Nausea—Cisplatin—lung cancer	0.000331	0.0004	CcSEcCtD
Linezolid—Cough—Methotrexate—lung cancer	0.000327	0.000396	CcSEcCtD
Linezolid—Convulsion—Methotrexate—lung cancer	0.000325	0.000393	CcSEcCtD
Linezolid—Vomiting—Etoposide—lung cancer	0.000325	0.000393	CcSEcCtD
Linezolid—Erythema—Doxorubicin—lung cancer	0.000325	0.000393	CcSEcCtD
Linezolid—Rash—Etoposide—lung cancer	0.000322	0.000389	CcSEcCtD
Linezolid—Dermatitis—Etoposide—lung cancer	0.000322	0.000389	CcSEcCtD
Linezolid—MAOB—Metabolism—RRM1—lung cancer	0.000321	0.00194	CbGpPWpGaD
Linezolid—MAOB—Metabolism—GSTA3—lung cancer	0.000321	0.00194	CbGpPWpGaD
Linezolid—Headache—Etoposide—lung cancer	0.00032	0.000387	CcSEcCtD
Linezolid—Flatulence—Doxorubicin—lung cancer	0.00032	0.000387	CcSEcCtD
Linezolid—Vomiting—Paclitaxel—lung cancer	0.000319	0.000385	CcSEcCtD
Linezolid—Dysgeusia—Doxorubicin—lung cancer	0.000318	0.000384	CcSEcCtD
Linezolid—Rash—Paclitaxel—lung cancer	0.000316	0.000382	CcSEcCtD
Linezolid—Dermatitis—Paclitaxel—lung cancer	0.000316	0.000381	CcSEcCtD
Linezolid—Headache—Paclitaxel—lung cancer	0.000314	0.000379	CcSEcCtD
Linezolid—MAOA—Metabolism—PLBD1—lung cancer	0.000313	0.00189	CbGpPWpGaD
Linezolid—Muscle spasms—Doxorubicin—lung cancer	0.000312	0.000377	CcSEcCtD
Linezolid—MAOA—Transmission across Chemical Synapses—BRAF—lung cancer	0.000306	0.00185	CbGpPWpGaD
Linezolid—Anaphylactic shock—Methotrexate—lung cancer	0.000306	0.00037	CcSEcCtD
Linezolid—Vision blurred—Doxorubicin—lung cancer	0.000306	0.00037	CcSEcCtD
Linezolid—Asthenia—Docetaxel—lung cancer	0.000305	0.000368	CcSEcCtD
Linezolid—Nausea—Etoposide—lung cancer	0.000304	0.000367	CcSEcCtD
Linezolid—MAOB—Metabolism—B4GALT5—lung cancer	0.000302	0.00182	CbGpPWpGaD
Linezolid—Pruritus—Docetaxel—lung cancer	0.0003	0.000363	CcSEcCtD
Linezolid—Anaemia—Doxorubicin—lung cancer	0.0003	0.000363	CcSEcCtD
Linezolid—Thrombocytopenia—Methotrexate—lung cancer	0.0003	0.000362	CcSEcCtD
Linezolid—Nausea—Paclitaxel—lung cancer	0.000298	0.00036	CcSEcCtD
Linezolid—Skin disorder—Methotrexate—lung cancer	0.000297	0.000359	CcSEcCtD
Linezolid—Hyperhidrosis—Methotrexate—lung cancer	0.000296	0.000358	CcSEcCtD
Linezolid—MAOB—Metabolism—GSTA4—lung cancer	0.000294	0.00177	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—CXCL8—lung cancer	0.000293	0.00177	CbGpPWpGaD
Linezolid—Vertigo—Doxorubicin—lung cancer	0.000292	0.000353	CcSEcCtD
Linezolid—Anorexia—Methotrexate—lung cancer	0.000292	0.000353	CcSEcCtD
Linezolid—Leukopenia—Doxorubicin—lung cancer	0.000291	0.000351	CcSEcCtD
Linezolid—Diarrhoea—Docetaxel—lung cancer	0.000291	0.000351	CcSEcCtD
Linezolid—MAOB—Metabolism—GSTA2—lung cancer	0.000286	0.00173	CbGpPWpGaD
Linezolid—MAOA—Metabolism—HSD17B10—lung cancer	0.000286	0.00173	CbGpPWpGaD
Linezolid—Cough—Doxorubicin—lung cancer	0.000283	0.000343	CcSEcCtD
Linezolid—Convulsion—Doxorubicin—lung cancer	0.000281	0.00034	CcSEcCtD
Linezolid—Dizziness—Docetaxel—lung cancer	0.000281	0.000339	CcSEcCtD
Linezolid—Hypertension—Doxorubicin—lung cancer	0.00028	0.000339	CcSEcCtD
Linezolid—MAOA—SIDS Susceptibility Pathways—CASP3—lung cancer	0.00028	0.00169	CbGpPWpGaD
Linezolid—Insomnia—Methotrexate—lung cancer	0.000277	0.000335	CcSEcCtD
Linezolid—MAOB—Metabolism—GSTA1—lung cancer	0.000276	0.00167	CbGpPWpGaD
Linezolid—Paraesthesia—Methotrexate—lung cancer	0.000275	0.000332	CcSEcCtD
Linezolid—MAOB—Metabolism—ABCC3—lung cancer	0.000273	0.00165	CbGpPWpGaD
Linezolid—Dyspnoea—Methotrexate—lung cancer	0.000273	0.00033	CcSEcCtD
Linezolid—Somnolence—Methotrexate—lung cancer	0.000272	0.000329	CcSEcCtD
Linezolid—MAOA—SIDS Susceptibility Pathways—JUN—lung cancer	0.000272	0.00164	CbGpPWpGaD
Linezolid—Dry mouth—Doxorubicin—lung cancer	0.00027	0.000327	CcSEcCtD
Linezolid—Vomiting—Docetaxel—lung cancer	0.00027	0.000326	CcSEcCtD
Linezolid—Dyspepsia—Methotrexate—lung cancer	0.000269	0.000326	CcSEcCtD
Linezolid—Rash—Docetaxel—lung cancer	0.000268	0.000324	CcSEcCtD
Linezolid—Dermatitis—Docetaxel—lung cancer	0.000268	0.000323	CcSEcCtD
Linezolid—Decreased appetite—Methotrexate—lung cancer	0.000266	0.000322	CcSEcCtD
Linezolid—Headache—Docetaxel—lung cancer	0.000266	0.000322	CcSEcCtD
Linezolid—MAOA—Metabolism—CKB—lung cancer	0.000266	0.0016	CbGpPWpGaD
Linezolid—Anaphylactic shock—Doxorubicin—lung cancer	0.000265	0.00032	CcSEcCtD
Linezolid—MAOB—Metabolism—AKR1C1—lung cancer	0.000264	0.0016	CbGpPWpGaD
Linezolid—Gastrointestinal disorder—Methotrexate—lung cancer	0.000264	0.000319	CcSEcCtD
Linezolid—Fatigue—Methotrexate—lung cancer	0.000264	0.000319	CcSEcCtD
Linezolid—Pain—Methotrexate—lung cancer	0.000262	0.000316	CcSEcCtD
Linezolid—Thrombocytopenia—Doxorubicin—lung cancer	0.00026	0.000314	CcSEcCtD
Linezolid—Skin disorder—Doxorubicin—lung cancer	0.000257	0.000311	CcSEcCtD
Linezolid—MAOB—Metabolism—UGT1A1—lung cancer	0.000257	0.00155	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—MDM2—lung cancer	0.000256	0.00155	CbGpPWpGaD
Linezolid—Hyperhidrosis—Doxorubicin—lung cancer	0.000256	0.00031	CcSEcCtD
Linezolid—MAOA—Transmission across Chemical Synapses—RAF1—lung cancer	0.000256	0.00154	CbGpPWpGaD
Linezolid—Anorexia—Doxorubicin—lung cancer	0.000253	0.000305	CcSEcCtD
Linezolid—Nausea—Docetaxel—lung cancer	0.000252	0.000305	CcSEcCtD
Linezolid—MAOA—SIDS Susceptibility Pathways—EP300—lung cancer	0.000251	0.00151	CbGpPWpGaD
Linezolid—Gastrointestinal pain—Methotrexate—lung cancer	0.00025	0.000303	CcSEcCtD
Linezolid—MAOA—Metabolism—CNDP2—lung cancer	0.00025	0.00151	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GSTM2—lung cancer	0.00025	0.00151	CbGpPWpGaD
Linezolid—MAOB—Metabolism—GNG11—lung cancer	0.000248	0.00149	CbGpPWpGaD
Linezolid—MAOA—Metabolism—MTMR3—lung cancer	0.000243	0.00147	CbGpPWpGaD
Linezolid—Urticaria—Methotrexate—lung cancer	0.000243	0.000294	CcSEcCtD
Linezolid—Body temperature increased—Methotrexate—lung cancer	0.000242	0.000292	CcSEcCtD
Linezolid—Abdominal pain—Methotrexate—lung cancer	0.000242	0.000292	CcSEcCtD
Linezolid—Insomnia—Doxorubicin—lung cancer	0.00024	0.00029	CcSEcCtD
Linezolid—Paraesthesia—Doxorubicin—lung cancer	0.000238	0.000288	CcSEcCtD
Linezolid—MAOA—SIDS Susceptibility Pathways—VEGFA—lung cancer	0.000238	0.00143	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PGAM1—lung cancer	0.000237	0.00143	CbGpPWpGaD
Linezolid—Dyspnoea—Doxorubicin—lung cancer	0.000236	0.000286	CcSEcCtD
Linezolid—MAOB—Metabolism—ALDOA—lung cancer	0.000236	0.00142	CbGpPWpGaD
Linezolid—Somnolence—Doxorubicin—lung cancer	0.000236	0.000285	CcSEcCtD
Linezolid—MAOA—Neuronal System—BRAF—lung cancer	0.000235	0.00142	CbGpPWpGaD
Linezolid—Dyspepsia—Doxorubicin—lung cancer	0.000233	0.000282	CcSEcCtD
Linezolid—Decreased appetite—Doxorubicin—lung cancer	0.00023	0.000278	CcSEcCtD
Linezolid—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000229	0.000277	CcSEcCtD
Linezolid—MAOB—Metabolism—NCOA3—lung cancer	0.000229	0.00138	CbGpPWpGaD
Linezolid—Fatigue—Doxorubicin—lung cancer	0.000229	0.000276	CcSEcCtD
Linezolid—Constipation—Doxorubicin—lung cancer	0.000227	0.000274	CcSEcCtD
Linezolid—Pain—Doxorubicin—lung cancer	0.000227	0.000274	CcSEcCtD
Linezolid—MAOA—Metabolism—CYP2A7—lung cancer	0.000226	0.00136	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ABCG2—lung cancer	0.000223	0.00134	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ADCY1—lung cancer	0.000223	0.00134	CbGpPWpGaD
Linezolid—MAOA—Metabolism—SDC4—lung cancer	0.000221	0.00134	CbGpPWpGaD
Linezolid—Asthenia—Methotrexate—lung cancer	0.00022	0.000265	CcSEcCtD
Linezolid—MAOB—Metabolism—ENO2—lung cancer	0.000218	0.00132	CbGpPWpGaD
Linezolid—MAOB—Metabolism—HPGDS—lung cancer	0.000218	0.00132	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PPP2R1B—lung cancer	0.000217	0.00131	CbGpPWpGaD
Linezolid—Gastrointestinal pain—Doxorubicin—lung cancer	0.000217	0.000262	CcSEcCtD
Linezolid—Pruritus—Methotrexate—lung cancer	0.000217	0.000262	CcSEcCtD
Linezolid—MAOB—Metabolism—GSTT1—lung cancer	0.000212	0.00128	CbGpPWpGaD
Linezolid—Urticaria—Doxorubicin—lung cancer	0.000211	0.000254	CcSEcCtD
Linezolid—Body temperature increased—Doxorubicin—lung cancer	0.00021	0.000253	CcSEcCtD
Linezolid—Abdominal pain—Doxorubicin—lung cancer	0.00021	0.000253	CcSEcCtD
Linezolid—Diarrhoea—Methotrexate—lung cancer	0.000209	0.000253	CcSEcCtD
Linezolid—MAOB—Metabolism—CYP2A6—lung cancer	0.000209	0.00126	CbGpPWpGaD
Linezolid—MAOB—Metabolism—GCLC—lung cancer	0.000209	0.00126	CbGpPWpGaD
Linezolid—Dizziness—Methotrexate—lung cancer	0.000202	0.000245	CcSEcCtD
Linezolid—MAOA—Metabolism—RRM1—lung cancer	0.000202	0.00122	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GSTA3—lung cancer	0.000202	0.00122	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ENO1—lung cancer	0.000198	0.0012	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—MDM2—lung cancer	0.000197	0.00119	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—RAF1—lung cancer	0.000196	0.00118	CbGpPWpGaD
Linezolid—Vomiting—Methotrexate—lung cancer	0.000195	0.000235	CcSEcCtD
Linezolid—Rash—Methotrexate—lung cancer	0.000193	0.000233	CcSEcCtD
Linezolid—Dermatitis—Methotrexate—lung cancer	0.000193	0.000233	CcSEcCtD
Linezolid—Headache—Methotrexate—lung cancer	0.000192	0.000232	CcSEcCtD
Linezolid—Asthenia—Doxorubicin—lung cancer	0.00019	0.00023	CcSEcCtD
Linezolid—MAOA—Metabolism—B4GALT5—lung cancer	0.000189	0.00114	CbGpPWpGaD
Linezolid—Pruritus—Doxorubicin—lung cancer	0.000188	0.000227	CcSEcCtD
Linezolid—MAOA—Metabolism—GSTA4—lung cancer	0.000184	0.00111	CbGpPWpGaD
Linezolid—Nausea—Methotrexate—lung cancer	0.000182	0.00022	CcSEcCtD
Linezolid—Diarrhoea—Doxorubicin—lung cancer	0.000181	0.000219	CcSEcCtD
Linezolid—MAOA—Metabolism—GSTA2—lung cancer	0.00018	0.00108	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CYP2E1—lung cancer	0.000178	0.00107	CbGpPWpGaD
Linezolid—MAOB—Metabolism—NQO1—lung cancer	0.000176	0.00106	CbGpPWpGaD
Linezolid—Dizziness—Doxorubicin—lung cancer	0.000175	0.000212	CcSEcCtD
Linezolid—MAOA—Metabolism—GSTA1—lung cancer	0.000173	0.00105	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ABCC3—lung cancer	0.000171	0.00103	CbGpPWpGaD
Linezolid—Vomiting—Doxorubicin—lung cancer	0.000169	0.000204	CcSEcCtD
Linezolid—Rash—Doxorubicin—lung cancer	0.000167	0.000202	CcSEcCtD
Linezolid—Dermatitis—Doxorubicin—lung cancer	0.000167	0.000202	CcSEcCtD
Linezolid—Headache—Doxorubicin—lung cancer	0.000166	0.000201	CcSEcCtD
Linezolid—MAOA—Metabolism—AKR1C1—lung cancer	0.000166	0.001	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—IL6—lung cancer	0.000164	0.000992	CbGpPWpGaD
Linezolid—MAOA—Metabolism—UGT1A1—lung cancer	0.000161	0.000972	CbGpPWpGaD
Linezolid—MAOB—Metabolism—STK11—lung cancer	0.000159	0.000957	CbGpPWpGaD
Linezolid—Nausea—Doxorubicin—lung cancer	0.000157	0.00019	CcSEcCtD
Linezolid—MAOA—Metabolism—GNG11—lung cancer	0.000155	0.000938	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ALDOA—lung cancer	0.000148	0.000893	CbGpPWpGaD
Linezolid—MAOB—Metabolism—GSTP1—lung cancer	0.000147	0.000886	CbGpPWpGaD
Linezolid—MAOA—Metabolism—NCOA3—lung cancer	0.000144	0.000867	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CAT—lung cancer	0.000143	0.000862	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—HRAS—lung cancer	0.000141	0.00085	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ABCG2—lung cancer	0.00014	0.000843	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ADCY1—lung cancer	0.00014	0.000843	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ABCB1—lung cancer	0.000139	0.000839	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ENO2—lung cancer	0.000137	0.000827	CbGpPWpGaD
Linezolid—MAOA—Metabolism—HPGDS—lung cancer	0.000137	0.000827	CbGpPWpGaD
Linezolid—MAOB—Metabolism—TYMS—lung cancer	0.000136	0.000824	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PPP2R1B—lung cancer	0.000136	0.000822	CbGpPWpGaD
Linezolid—MAOB—Metabolism—GSTM1—lung cancer	0.000135	0.000814	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GSTT1—lung cancer	0.000133	0.000802	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CYP2A6—lung cancer	0.000131	0.000793	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GCLC—lung cancer	0.000131	0.000793	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CYP1A1—lung cancer	0.000128	0.000772	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ERCC2—lung cancer	0.000127	0.000765	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ENO1—lung cancer	0.000124	0.000751	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CYP2E1—lung cancer	0.000112	0.000674	CbGpPWpGaD
Linezolid—MAOA—Metabolism—NQO1—lung cancer	0.00011	0.000666	CbGpPWpGaD
Linezolid—MAOB—Metabolism—APOA1—lung cancer	0.00011	0.000662	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—HRAS—lung cancer	0.000108	0.000651	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PIK3CG—lung cancer	0.0001	0.000604	CbGpPWpGaD
Linezolid—MAOA—Metabolism—STK11—lung cancer	9.95e-05	0.000601	CbGpPWpGaD
Linezolid—MAOB—Metabolism—POMC—lung cancer	9.53e-05	0.000575	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CREBBP—lung cancer	9.28e-05	0.00056	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GSTP1—lung cancer	9.21e-05	0.000556	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CAT—lung cancer	8.96e-05	0.000541	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PIK3CD—lung cancer	8.8e-05	0.000531	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ABCB1—lung cancer	8.72e-05	0.000526	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ALB—lung cancer	8.69e-05	0.000525	CbGpPWpGaD
Linezolid—MAOA—Metabolism—TYMS—lung cancer	8.56e-05	0.000517	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GSTM1—lung cancer	8.46e-05	0.000511	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CYP1A1—lung cancer	8.02e-05	0.000484	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ERCC2—lung cancer	7.96e-05	0.00048	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PIK3CB—lung cancer	7.67e-05	0.000463	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PTGS2—lung cancer	7.6e-05	0.000459	CbGpPWpGaD
Linezolid—MAOA—Metabolism—APOA1—lung cancer	6.88e-05	0.000415	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PTEN—lung cancer	6.63e-05	0.0004	CbGpPWpGaD
Linezolid—MAOB—Metabolism—EP300—lung cancer	6.32e-05	0.000382	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PIK3CG—lung cancer	6.28e-05	0.000379	CbGpPWpGaD
Linezolid—MAOA—Metabolism—POMC—lung cancer	5.98e-05	0.000361	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CREBBP—lung cancer	5.83e-05	0.000352	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PIK3CD—lung cancer	5.52e-05	0.000333	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ALB—lung cancer	5.45e-05	0.000329	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PIK3CB—lung cancer	4.81e-05	0.000291	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PTGS2—lung cancer	4.77e-05	0.000288	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PIK3CA—lung cancer	4.68e-05	0.000282	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PTEN—lung cancer	4.16e-05	0.000251	CbGpPWpGaD
Linezolid—MAOA—Metabolism—EP300—lung cancer	3.97e-05	0.000239	CbGpPWpGaD
Linezolid—MAOB—Metabolism—AKT1—lung cancer	3.82e-05	0.000231	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PIK3CA—lung cancer	2.94e-05	0.000177	CbGpPWpGaD
Linezolid—MAOA—Metabolism—AKT1—lung cancer	2.4e-05	0.000145	CbGpPWpGaD
